The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Antipsychotic Drug Use and Mortality in Older Adults with Dementia
Abstract
BACKGROUND: Antipsychotic drugs are widely used to manage behavioral and psychological symptoms in dementia despite concerns about their safety. OBJECTIVE: To examine the association between treatment with antipsychotics (both conventional and atypical) and all-cause mortality. DESIGN: Population-based, retrospective cohort study. SETTING: Ontario, Canada. PATIENTS: Older adults with dementia who were followed between 1 April 1997 and 31 March 2003. MEASUREMENTS: The risk for death was determined at 30, 60, 120, and 180 days after the initial dispensing of antipsychotic medication. Two pairwise comparisons were made: atypical versus no antipsychotic use and conventional versus atypical antipsychotic use. Groups were stratified by place of residence (community or long-term care). Propensity score matching was used to adjust for differences in baseline health status. RESULTS: A total of 27,259 matched pairs were identified. New use of atypical antipsychotics was associated with a statistically significant increase in the risk for death at 30 days compared with nonuse in both the community-dwelling cohort (adjusted hazard ratio, 1.31 [95% CI, 1.02 to 1.70]; absolute risk difference, 0.2 percentage point) and the long-term care cohort (adjusted hazard ratio, 1.55 [CI, 1.15 to 2.07]; absolute risk difference, 1.2 percentage points). Excess risk seemed to persist to 180 days, but unequal rates of censoring over time may have affected these results. Relative to atypical antipsychotic use, conventional antipsychotic use was associated with a higher risk for death at all time points. Sensitivity analysis revealed that unmeasured confounders that increase the risk for death could diminish or eliminate the observed associations. LIMITATIONS: Information on causes of death was not available. Many patients did not continue their initial treatments after 1 month of therapy. Unmeasured confounders could affect associations. CONCLUSIONS: Atypical antipsychotic use is associated with an increased risk for death compared with nonuse among older adults with dementia. The risk for death may be greater with conventional antipsychotics than with atypical antipsychotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A similar black box warning for conventional antipsychotics, based on two observational studies that showed increased risk of mortality in older adults using conventional versus atypical antipsychotics, was announced in 2008.117 118 119”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result, it announced a black box warning for the use of atypical antipsychotics for behavioral and psychological symptoms of dementia.”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In 2005, the FDA announced that, based on a re-analysis of 17 placebo controlled trials (several of which were unpublished), atypical antipsychotics were associated with a 1.7-fold increase in mortality compared with placebo.117 118”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A meta-analysis found an odds ratio for mortality with these drugs of 1.54 (1.06 to 2.23; Z=2.28; P=0.02), with pooled events of 3.5% mortality for the drug versus 2.3% for placebo.”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some studies have shown that nonpharmacological treatments pose fewer side effects, which render them as safer options [20].”
From Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review (2015) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Rosenbaum, P. R., & Rubin, D. B. (1985) · The American Statistician · doi:10.2307/2683903 · Cited by 6,472
Variable Selection for Propensity Score Models
Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj149 · Cited by 2,336
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
Schneider, L. S., Tariot, P. N., Dagerman, K. S., Davis, S. M., Hsiao, J. K., Ismail, M. S., Lebowitz, B. D., Lyketsos, C. G., Ryan, J. M., Stroup, T. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061240 · Cited by 1,206
Austin, P. C., Grootendorst, P. V., & Anderson, G. M. (2006) · Statistics in Medicine · doi:10.1002/sim.2580 · Cited by 1,138
Self-citationRisk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications
Wang, P. S., Schneeweiss, S., Avorn, J., Fischer, M. A., Mogun, H., Solomon, D. H., & Brookhart, M. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052827 · Cited by 959
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence
Sink, K. M., Holden, K. F., & Yaffe, K. (2005) · JAMA · doi:10.1001/jama.293.5.596 · Cited by 910
Effectiveness of Collaborative Care for Older Adults With Alzheimer Disease in Primary Care
Callahan, C. M., Boustani, M. A., Unverzagt, F. W., Austrom, M. G., Damush, T. M., Perkins, A. J., Fultz, B. A., Hui, S. L., Counsell, S. R., & Hendrie, H. C. (2006) · JAMA · doi:10.1001/jama.295.18.2148 · Cited by 799
Research works printed but not linked: 4
- Levy AR, 2003, Can J Clin Pharmacol, 10, 67
- 10.1080/00031305.1985.10479383 · DOI
- Trifirò G, 2006, Pharmacoepidemiol Drug Saf
- Gill SS, 2006, JAMA, 295, 495
Cited by
Sorted by citations
Items 401–500 of 618
Ramin, T., Peter, J., Schneider, M., Dahling, V., & Zolk, O. (2025) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70142 · Cited by 5
Psychotropic drugs for the behavioural and psychological symptoms of dementia: no free ride
Abi‐Jaoude, E., Stall, N. M., & Rochon, P. A. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.181486 · Cited by 5
Self-citationRashid, N., Wetmore, J. B., Irfan, M., Peng, Y., & Abler, V. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000401 · Cited by 5
Karlsen, I., Kristiansen, J., Jaspers, S. Ø., Rasmussen, L., Laursen, L. L., Bengtsen, E., & Aust, B. (2023) · Aggression and Violent Behavior · doi:10.1016/j.avb.2023.101843 · Cited by 5
Pharmacological interventions for the treatment of delirium in critically ill patients
Burry, L. D., Mehta, S., Williamson, D. R., Hutton, B., Ely, E. W., Adhikari, N. K. J., Egerod, I., Fergusson, D. A., & Rose, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011749 · Cited by 5
Szmulewicz, A., Ferraris, A., Rodriguez, A., Cervera, L. V. C., González, M. L., Man, F., Angriman, F., & Martino, D. J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.034 · Cited by 5
Association of PTHrP levels in CSF with Alzheimer’s disease biomarkers
Kushnir, M. M., Michno, W., Rockwood, A. L., Blennow, K., Strathmann, F. G., & Hanrieder, J. (2018) · Clinical mass spectrometry · doi:10.1016/j.clinms.2018.10.001 · Cited by 5
Moving Towards Wellness in Long-term Care: Considerations for Dementia-Associated Aggression
Goldstein‐Levitas, N. (2019) · American Journal of Dance Therapy · doi:10.1007/s10465-019-09303-9 · Cited by 7
Which Psychotropics Carry the Greatest Risk of QTc Prolongation
Washington, N. B., Brahm, N. C., & Kissack, J. C. (2012) · Current psychiatry · Cited by 5
Piccinni, C. P., Dondi, L., Ronconi, G., Calabria, S., Esposito, I., Pedrini, A., Maggioni, A. P., Barbui, C., & Martini, N. (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-02899-9 · Cited by 5
Indicators of dementia disease progression in primary care: An electronic health record cohort study
Rathod‐Mistry, T., Marshall, M. B., Campbell, P., Bailey, J., Chew-Graham, C. A., Croft, P. R., Frisher, M., Hayward, R. A., Negi, R., Robinson, L. A., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14710 · Cited by 5
Treatment of cognitive impairment in arterial hypertension
Starchina, Y. A., & Sleptcova, K. S. (2021) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2021-5-90-95 · Cited by 5
Potentially inappropriate medications in relation to length of nursing home stay among older adults
Sönnerstam, E., Gustafsson, M. V., & Lövheim, H. (2022) · BMC Geriatrics · doi:10.1186/s12877-021-02639-3 · Cited by 7
Sönnerstam, E., Harlin, F., & Gustafsson, M. V. (2023) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2023.01.010 · Cited by 5
Psychopharmacology in Primary Care Settings
Benich, J. J., Bragg, S. W., & Freedy, J. R. (2016) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2016.01.002 · Cited by 5
Adverse Effects of Antipsychotics
Landry, P., Rousseau, A., & Skalli, L. (2010) · Wiley eBooks · doi:10.1002/9780470749180.ch17 · Cited by 5
Identifying and Resolving Drug-Related Problems in Geriatric Patients
Peterson, M. E., Stollings, J. L., & Ely, E. W. (2026) · Hospital Pharmacy · doi:10.1177/00185787251414339 · Cited by 6
New opioid use and mortality in older people with dementia
Jensen‐Dahm, C., Janbek, J., Laursen, T. M., Gasse, C., & Waldemar, G. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251352469 · Cited by 4
Pratt, N. L., Roughead, E. E., Salter, A. B., & Ryan, P. (2010) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2010.00613.x · Cited by 4
Wang, S., Temkin‐Greener, H., Conwell, Y., & Cai, S. (2022) · Journal of Applied Gerontology · doi:10.1177/07334648221102402 · Cited by 4
Wang, M., Ma, Y., Shen, Z., Jiang, L., Zhang, X., Wei, X., Han, Z., Liu, H., & Yang, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.925583 · Cited by 4
Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012
Hernandez, I., & Zhang, Y. (2017) · Gerontology and Geriatric Medicine · doi:10.1177/2333721417704946 · Cited by 4
Pharmacological alternatives to antipsychotics to manage BPSD
Mishriky, R. S. L., & Reyad, A. A. (2018) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.495 · Cited by 5
Wang, G., Albayrak, A., Molenbroek, J. F. M., & van der Cammen, T. J. M. (2018) · Advances in intelligent systems and computing · doi:10.1007/978-3-319-96065-4_15 · Cited by 4
Rashid, N., Wetmore, J. B., Irfan, M., & Abler, V. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221081374 · Cited by 4
Romero, G. M., Martí, J. F. P., Fayos, J. G., Gosalbez, M. N., Vargas, I. Q., & Tirado, J. M. (2010) · Farmacia Hospitalaria (English Edition) · doi:10.1016/s2173-5085(10)70008-3 · Cited by 4
Caring for the Elderly in an Inpatient Setting: Managing Insomnia and Polypharmacy
Kim, J. J., Tofade, T. S., Peckman, H. J., & Tofade, T. S. (2009) · Journal of Pharmacy Practice · doi:10.1177/0897190008330199 · Cited by 4
Risk excess of mortality and use of antipsychotics
Arias, L. H. M., Lobato, C. T., García, S. P., Sáinz-Gil, M., Fadrique, R. S., & Ortega, P. G. (2016) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000146 · Cited by 4
Clinical Pharmacology and Vascular Risk~!2009-05-11~!2009-12-22~!2010-06-14~!
Silvestrelli, G., Corea, F., Micheli, S., & Lanari, A. (2010) · The Open Neurology Journal · doi:10.2174/1874205x01004020064 · Cited by 4
Antipsychotics: features of undesirable adverse reactions in elderly and senile age
Ostroumova, O. D., Васильевна, Г. И., Isaev, R. I., & Pereverzev, A. P. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2019119021105 · Cited by 4
Locca, J.-F., Büla, C., Zumbach, S., & Bugnon, O. (2008) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2008.09.001 · Cited by 5
Tratamiento de la enfermedad de Alzheimer
Toledo, M. B. (2007) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(07)75475-9 · Cited by 4
Antipsychotic induced parkinsonism in the elderly: assessment, causes and consequences
Knol, W. (2011) · Utrecht University Repository (Utrecht University) · Cited by 4
Gardner, D. M., Teehan, M. D., & Baldessarini, R. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511919237.006 · Cited by 4
Jönsson, L., Wibom, M., Londos, E., & Nägga, K. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70057 · Cited by 3
Geum, M. J., Yoo, S. H., Lee, S. W., Hong, M., Jung, E. H., Kim, Y. J., & Kang, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-23079-8 · Cited by 3
Kröger, E., Wilchesky, M., Morin, M., Carmichael, P., Marcotte, M., Misson, L., Plante, J., Voyer, P., & Durand, P. J. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04222-4 · Cited by 3
Receptor-Independent Therapies for Forensic Detainees with Schizophrenia–Dementia Comorbidity
Sfera, A., Andronescu, L., Britt, W. G., Himsl, K., Klein, C. A., Rahman, L., & Kozlakidis, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115797 · Cited by 3
Scandashree, K., Praveenkumar, B., & Udaykumar, P. (2016) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20163102 · Cited by 3
Reverté‐Villarroya, S., Zaragoza-Brunet, J., Matamoros-Obiol, C., Inglada-García, E., Arroyo, S. E., Forcadell-Ferreres, E., & Esteve‐Belloch, P. (2019) · Revista Científica de la Sociedad de Enfermería Neurológica (English ed ) · doi:10.1016/j.sedeng.2019.08.001 · Cited by 3
„Deprescribing“ von Antipsychotika bei Demenz
Roßmeier, C., Gast, J., Riedl, L., Hartmann, J., Kohl, S., Hartmann, F., & Diehl‐Schmid, J. (2022) · Der Nervenarzt · doi:10.1007/s00115-022-01343-w · Cited by 3
Kindstedt, J., Glader, E., Lövheim, H., Lindkvist, M., & Gustafsson, M. V. (2023) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.6018 · Cited by 3
Hirayama, T., Igarashi, E., Wada, S., Sadahiro, R., Oshikiri, H., Suzuka, M., Sato, Y., Utsumi, Y., Sakuma, A., Nakahara, R., et al. (2024) · Palliative & Supportive Care · doi:10.1017/s1478951524000117 · Cited by 3
Antipsychotic Prescribing in Older Adults after In-Hospital Initiation
Madey, J., Tri, S., Haines, A., Zimmer, S., Halpape, K., & Dumont, Z. J. (2024) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.3543 · Cited by 3
Acute Kidney Injury and Mortality in the Elderly: Add Atypical Antipsychotics to the List
Moledina, D. G., & Perazella, M. A. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.01.005 · Cited by 3
A patient-centered model of the action of psychotropic drugs
Rajkumar, R. P. (2015) · Personalized Medicine Universe · doi:10.1016/j.pmu.2015.03.001 · Cited by 3
Wooten, J. M. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e318153f180 · Cited by 3
Nonpharmacological Management of BPSD: Agitation and Behavioral Problems in Dementia
Chang, C. (2019) · Springer eBooks · doi:10.1007/978-3-030-19625-7_21 · Cited by 3
Sönnerstam, E., Gustafsson, M. V., Lövheim, H., & Sjölander, M. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00947-w · Cited by 3
Jaworska, N., Makuk, K., Krewulak, K. D., Niven, D. J., Ismail, Z., Burry, L. D., Mehta, S., & Fiest, K. M. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000806 · Cited by 3
Tsai, D. H., Chang, W. H., Lin, H., Lin, S., Shao, S., & Lai, E. C. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103533 · Cited by 3
An Update On the Neuropsychiatric Symptoms of Dementia
Herrmann, N. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.41 · Cited by 3
Self-citationRisk Evaluation for Antipsychotic Agents Used in Elderly Inpatients (REPAIR)
Yu, F., Rafizadeh, R., Mabasa, V. H., & Kang, N. (2019) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v71i6.2852 · Cited by 3
Agitation in Patients with Dementia - Challenges in Diagnosis and Treatment
Sommer, O. H. (2010) · NORA - Norwegian Open Research Archives · Cited by 3
Kashimura, M., Nomura, T., Ishiwata, A., Tateno, A., Nogami, A., Kitamura, S., & Spector, A. E. (2022) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x22000514 · Cited by 2
Stuber, M. J., Brockhus, L., Spinewine, A., O’Mahony, D., Jennings, E. L. M., Dalleur, O., Knol, W., Koek, H. L., Baggio, S., Rodondi, N., et al. (2025) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70049 · Cited by 2
Terao, I., & Kodama, W. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.70051 · Cited by 3
Everson-Hock, E., Waters, B., Griffiths, A. W., Fisher, E., Backhouse, T., Cunha, I. F., Scott, S., Giebel, C. M., Jones, L., Mehta, J., et al. (2026) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2026.105347 · Cited by 2
Romero, G. M., Martí, J. F. P., Fayos, J. G., Gosalbez, M. N., Vargas, I. Q., & Tirado, J. M. (2010) · Farmacia Hospitalaria · doi:10.1016/j.farma.2009.10.010 · Cited by 2
Lautenschlager, M. M., Lautenschlager, N. T., & Förstl, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_66 · Cited by 2
Basaeed, A. J., Wafia, G., Alhidri, B., Sindi, L. A., Hakami, A. Y., & Jastaniah, N. A. (2022) · Cureus · doi:10.7759/cureus.30460 · Cited by 2
Rantsi, M., Kortelainen, L., Hyttinen, V., Jyrkkä, J., & Kankaanpää, E. (2023) · Age and Ageing · doi:10.1093/ageing/afad094 · Cited by 2
Zhang, A. D., Zepel, L., Woolson, S., Miller, K. E. M., Schleiden, L. J., Shepherd‐Banigan, M. E., Thorpe, J. M., & Hastings, S. N. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.09.010 · Cited by 2
Reverté‐Villarroya, S., Zaragoza-Brunet, J., Matamoros-Obiol, C., Inglada-García, E., Arroyo, S. E., Forcadell-Ferreres, E., & Esteve‐Belloch, P. (2019) · Revista Científica de la Sociedad Española de Enfermería Neurológica · doi:10.1016/j.sedene.2019.08.001 · Cited by 2
Boushra, M. N., & Nagalli, S. (2021) · StatPearls · Cited by 2
Tidmore, L. M., & Skrepnek, G. H. (2022) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000509 · Cited by 2
Antipsychotics in Alzheimer’s Disease: Current Status and Therapeutic Alternatives
Maziero, M. P., Rocha, N. P., & Teixeira, A. L. (2023) · Current Alzheimer Research · doi:10.2174/0115672050287534240215052417 · Cited by 2
Martínez, L. M., Fernández, M. R. O., & Corrales, G. P. (2009) · Farmacia Hospitalaria (English Edition) · doi:10.1016/s2173-5085(09)70088-7 · Cited by 2
Consultation liaison psychiatry and emergency medicine in Japan
Kishi, Y., & Kurosawa, H. (2010) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.3893/jjaam.21.147 · Cited by 2
Tamblyn, R. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-32304-6_20 · Cited by 2
Rehabilitation in Dementia Care
Hurzuk, S., & Ambali, A. P. (2021) · Springer eBooks · doi:10.1007/978-981-16-3864-0_11 · Cited by 2
An economic evaluation of antipsychotic medications given to persons with dementia
Brent, R. J. (2024) · Applied Economics · doi:10.1080/00036846.2024.2339187 · Cited by 3
Zhou, J., Wei, Z., Huang, W., Liu, M., & Wu, X. (2024) · Annals of Pharmacotherapy · doi:10.1177/10600280241271093 · Cited by 3
Pharmacokinetics and Pharmacodynamics in Late Life
Bigos, K. L., Bies, R. R., & Pollock, B. G. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199796816.003.0038 · Cited by 2
Tratamiento de la enfermedad de Alzheimer
Luque, M. L., de León, J. M. R. S., Izquierdo, P., & García, C. F. (2011) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(11)70069-5 · Cited by 5
Improving long-term care services: insights from high-reliability organizations
Zadeh, M. M., & Haggerty, N. (2021) · Leadership in health services · doi:10.1108/lhs-07-2021-0064 · Cited by 2
Response: The Association of Antipsychotics with Mortality Among Elderly Patients With Dementia
Raivio, M., Strandberg, T. E., Tilvis, R. S., Laurila, J., & Pitkälä, K. H. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181557941 · Cited by 2
When one size doesn’t fit all: Agitation in older adults requires a tailored approach
Goldberg, E. M., Zullo, A. R., & Beaudoin, F. L. (2021) · Academic Emergency Medicine · doi:10.1111/acem.14267 · Cited by 2
Psychosocial interventions for reducing antipsychotic medication in care home residents
Richter, T., Meyer, G., & Köpke, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008634 · Cited by 3
Antipsychotic medications and risk of respiratory failure in the respiratory high dependency unit
Winter, S., Kirkpatrick, T., Winckel, K., Honarparvar, F., Robinson, L., Tanzer, T. D., Smith, L., Warren, N., Siskind, D. J., & Ellender, C. M. (2024) · BJPsych Open · doi:10.1192/bjo.2024.773 · Cited by 1
Neuropsychiatric Symptoms and Mortality in Cognitively Normal Older Mexican Americans
Cantu, P. A., Snih, S. A., Markides, K., & Raji, M. A. (2025) · Hispanic Journal of Behavioral Sciences · doi:10.1177/07399863241310476 · Cited by 1
Organ Dysfunction in Sepsis: Brain, Neuromuscular, Cardiovascular, and Gastrointestinal
Anderson, B. J., & Mikkelsen, M. E. (2017) · Respiratory medicine · doi:10.1007/978-3-319-48470-9_10 · Cited by 1
Mao, M., Du, S., Xu, Y., Li, Q., Luo, R., Zhou, Q., & Hu, X. (2025) · Scientific Reports · doi:10.1038/s41598-024-84064-1 · Cited by 1
Skin Biopsy Diagnosis of Late-Onset Psychosis as Prodromal Dementia With Lewy Bodies: A Case Series
Butler, T. (2025) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20250066 · Cited by 1
Prescribing and deprescribing of atypical antipsychotics in older multimorbid patients
Schneider, C., O’Mahony, D., Byrne, S., Dalleur, O., Spinewine, A., Huibers, C. J. A., Knol, W., Rodondi, N., & Aubert, C. E. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06579-0 · Cited by 1
Sinvani, L., Nelson, S., Perrin, A., Islam, S., Sison, C. P., Slotnick, S., Chua, V., Porreca, K., Barnaby, D. P., Kwiatek, S., et al. (2026) · Journal of General Internal Medicine · doi:10.1007/s11606-026-10544-x · Cited by 1
Five ethical questions involving Alzheimer's disease.
Howe, E. G. (2007) · PubMed Central · Cited by 1
Peut-on se former à la dignité ?
Noëttes, V. L. D., & Bivic, C. L. (2013) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2013.03.006 · Cited by 1
Effect and tolerability of blonanserin in severe delusion with various types of dementia
Takaki, M., Honda, H., Terada, S., & Uchitomi, Y. (2014) · Psychogeriatrics · doi:10.1111/psyg.12090 · Cited by 1
Specialty Payment Model Opportunities and Design
McClellan, M., Patel, K., Botts, C., Presser, E., Grimes, C., Crim, C., & Tobin, J. (2014) · Cited by 1
Ling, T. L. (2016) · Journal of Gerontology & Geriatric Research · doi:10.4172/2167-7182.1000276 · Cited by 1
Dadarwala, D., Kedare, J. S., Pusalkar, A., Subramanyam, A. A., & Kamath, R. M. (2017) · Journal of Geriatric Mental Health · doi:10.4103/jgmh.jgmh_6_17 · Cited by 1
The pharmacological treatment of behavioral alterations in the course of dementia
Cristina, D. (2022) · Journal of Geriatric Mental Health · doi:10.4103/jgmh.jgmh_18_22 · Cited by 1
Julião, M., Bruera, E. D., Silva, C., Calado, J., Cruz, M., Vaz, M., & Paiva, B. S. R. (2023) · Palliative & Supportive Care · doi:10.1017/s147895152300007x · Cited by 1
Dementia and mortality in older adults: A twin study
Jang, J. Y., Beam, C. R., Karlsson, I., Pedersen, N. L., & Gatz, M. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13553 · Cited by 1
Rao, S., McQuay, L. J., Forns, J., MacKay, R. E., Danysh, H. E., Doshi, D., Abler, V., Anthony, M. S., & Layton, J. B. (2025) · Drug Safety · doi:10.1007/s40264-025-01543-8 · Cited by 1
Reisinho, P., Raposo, R., Ribeiro, Ó. M., Zagalo, N., & Silva, J. (2025) · Lecture notes in computer science · doi:10.1007/978-3-031-97766-4_14 · Cited by 1
Central Nervous System (CNS) Medications and Delirium
Fick, D. M. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0912-0_20 · Cited by 1
Bilotta, C., Franchi, C., Nobili, A., Nicolini, P., Djade, C. D., Tettamanti, M., Pasina, L., Fortino, I., Bortolotti, A., Merlino, L. G., et al. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1750-6 · Cited by 1
Gruneir, A., Marras, C., Fischer, H. D., Wang, X., Gill, S. S., Rochon, P. A., & Anderson, G. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2058 · Cited by 1
Self-citation
Metadata
- Authors
- Gill, S. S., Bronskill, S. E., Normand, S.-L. T., Anderson, G. M., Sykora, K., Lam, K., Bell, C. M., Lee, P. E., Fischer, H. D., Herrmann, N., Gurwitz, J. H., & Rochon, P. A.
- Affiliations
- Harvard University (US)
- From Queen's University, Kingston, Ontario, Canada; Institute for Clinical Evaluative Sciences and University of Toronto, Toronto, Ontario, Canada; Harvard Medical School and Harvard School of Public Health, Boston, Massachusetts; University of British Columbia, Vancouver, British Columbia, Canada; and Meyers Primary Care Institute of the University of Massachusetts Medical School, Fallon Clinic Foundation, and Fallon Community Health Plan, Worcester, Massachusetts.
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2007-06-05
- Volume
- 146
- Issue
- 11
- Pages
- 775-786
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2144855317
- Cited by
- 624
- References
- 66
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 22 · 2022: 30 · 2021: 18 · 2020: 27 · 2019: 31 · 2018: 38 · 2017: 36 · 2016: 45 · 2015: 42 · 2014: 30 · 2013: 37 · 2012: 35
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- antipsychotic drugs, atypical antipsychotics, typical antipsychotics, dementia, all-cause mortality, older adults, behavioral and psychological symptoms of dementia, long-term care, community-dwelling older adults, drug safety
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Humans, Male, Ontario, Sensitivity and Specificity, Time Factors, Antipsychotic Agents, Matched-Pair Analysis, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
